(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MACOMICS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MACOMICS

ST13

US500000079310228

Class

42

Filing

79310228

Registration

6770076

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

05/15/2026

Trademark type

Word

Nice classes

42

Filing date

02/11/2021

Registration date

06/28/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/28/2022

Last transaction

05/15/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

GB

Examiner

MESSICK, TABITHA LEE

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Macomics Ltd

Representatives

Matthew L. Frisbee Leason Ellis LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Scientific and technological servicesnamely research and design in the field of medicine and medical therapies; medical research and pharmacological research services; medical laboratory services; medical research laboratory services; research and development of medicinespharmaceuticalsdrugs and medical treatments; research into and development of medical therapies; research into and development of immunotherapies; research into and development of medical therapies that modulate macrophages; research into and development of medical therapies that increase the body's immune defence against tumours; medical scientific research services relating to the discoverypreclinical and clinical development of therapeutic products; research into and development of cancer and tumour treatments; research and development services in the field of oncology; consultancyadvice and information for the aforesaid services

Publications

History of USPTO decisions and trademark events.

26 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/14/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/12/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/12/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/12/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/01/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

10/07/2022

FIMP

FINAL DISPOSITION PROCESSED

10/07/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/28/2022

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/28/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

06/28/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/12/2022

PUBO

PUBLISHED FOR OPPOSITION

04/12/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/23/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/10/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/02/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/02/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/02/2022

RFNT

REFUSAL PROCESSED BY IB

10/25/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/27/2021

RFRR

REFUSAL PROCESSED BY MPU

09/27/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/14/2021

CNRT

NON-FINAL ACTION WRITTEN

09/13/2021

DOCK

ASSIGNED TO EXAMINER

09/08/2021

MAFR

APPLICATION FILING RECEIPT MAILED

05/15/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/11/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/08/2021

Continuous trademark protection

Get notified about every new filing that threatens MACOMICS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.